Zepp Health reports Q2 adjusted EPS (15c) vs. (14c) last year

Reports Q2 revenue $40.6M vs. $92.4M last year. Wang Huang, chairman and CEO of Zepp, commented, “Our second quarter performance aligned with our guidance, highlighted by a sequential increase in self-branded product sales and the achievement of a historically high gross margin. Despite a year-over-year decline in revenue, we are confident that the most challenging phase of our transformation has now been successfully navigated.”